Infectious Diseases Study Experience
The need is growing rapidly for effective therapies to treat infectious diseases, and developing those therapies is more complex than ever. At PPD, we understand the challenges and help our clients navigate and minimize the complexities. Our understanding begins with well-written concepts and protocols that serve as the roadmap to developing the optimal plans for anti-infective, antifungal, antiviral and vaccine studies.
With our global network of therapeutic and regulatory experts, we help clients understand standards of care and regulations every step of the way to ensure that timelines are met.
In the past five years, our infectious diseases team:
- Conducted more than 200 studies1 in all major markets in more than 50 countries
- Enrolled more than 230,000 patients at more than 9,000 sites1
1. These numbers don't include our work in the nontraditional services sector, which is managed separately.
